Sfoglia per Rivista CANCER RESEARCH
Quantitative Assessment of the Complex Dynamics of G(1), S, and G(2)-M Checkpoint Activities
2009-01-01 Ubezio, P; Lupi, M; Branduardi, D; Cappella, P; Cavallini, E; Colombo, V; Matera, G; Natoli, C; Tomasoni, D; D'Incalci, M
Second primary tumors after breast cancer: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) study
2012-01-01 Ricceri, F; Sacerdote, C; Critelli, R; Vineis, P; Riboli, E
Selective expression and constitutive phosphorylation of SHC proteins [corrected] in the CD34+ fraction of chronic myelogenous leukemias
2000-01-01 Bonati, A.; Carlo-Stella, C.; Lunghi, P.; Albertini, R.; Pinelli, S.; Migliaccio, E.; Sammarelli, G.; Savoldo, B.; Tabilio, A.; Dall'Aglio, P. P.; Pelicci, P. G.
Specific histone patterns and acetylase/deacetylase activity at the breakpoint-cluster region of the human MLL gene
2004-01-01 Khobta, A.; Carlo Stella, C.; Capranico, G.
Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line
2005-01-01 Zongaro, S; de Stanchina, E; Colombo, T; D'Incalci, M; Giulotto, E; Mondello, C
Striking activity of E-3810 combined with paclitaxel and 5FU in the triple negative breast cancer model MDA-MB-231
2011-01-01 Damia, G; Bello, E; Colella, G; Berndt, A; D'Incalci, M; Cavalletti, E; Camboni, G
Tenascin-W is a novel marker for activated tumor stroma in low-grade human breast cancer and influences cell behavior
2007-01-01 Degen, M; Brellier, F; Kain, R; Ruiz, C; Terracciano, L; Orend, G; CHIQUET-EHRISMANN, R
The anti-HLA-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing NOD/SCID mice
2006-01-01 Carlo-Stella, C.; Di Nicola, M.; Turco, M. C.; Cleris, L.; Lavazza, C.; Longoni, P.; Milanesi, M.; Magni, M.; Ammirante, M.; Leone, A.; Nagy, Z.; Gioffrè, W. R.; Formelli, F.; Gianni, A. M.
The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: Regulation of expression and potential mechanisms of antimalignant activity
2003-01-01 Monti, P; Leone, Be; Marchesi, F; Balzano, G; Zerbi, A; Scaltrini, F; Pasquali, C; Calori, G; Pessi, F; Sperti, C; Di Carlo, V; Allavena, P; Piemonti, L
TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: A prospective study
2006-01-01 Gormally, E; Vineis, P; Matullo, G; Veglia, F; Caboux, E; Le Roux, E; Peluso, M; Garte, S; Guarrera, S; Munnia, A; Airoldi, L; Autrup, H; Malaveille, C; Dunning, A; Overvad, K; Tjonneland, A; Lund, E; Clavel-Chapelon, F; Boeing, H; Trichopoulou, A; Palli, D; Krogh, V; Tumino, R; Panico, S; Bueno-de-Mesquita, Hb; Peeters, Ph; Pera, G; Martinez, C; Dorronsoro, M; Barricarte, A; Navarro, C; Quiros, Jr; Hallmans, G; Day, Ne; Key, Tj; Saracci, R; Kaaks, R; Riboli, E; Hainaut, P
Tumor hypoxia does not drive differentiation of tumor-associated macrophages but rather fine-tunes the M2-like macrophage population
2014-01-01 Laoui, D.; Van Overmeire, E.; Conza, G. D.; Aldeni, C.; Keirsse, J.; Morias, Y.; Movahedi, K.; Houbracken, I.; Schouppe, E.; Elkrim, Y.; Karroum, O.; Jordan, B.; Carmeliet, P.; Gysemans, C.; Debaetselier, P.; Mazzone, M.; Van Ginderachter, J. A.
Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model
2002-01-01 Janssen, Ml; Oyen, W; Dijkgraaf, I; Massuger, Lf; Frielink, C; Edwards, Ds; Rajopadhye, M; Boonstra, H; Corstens, Fh; Boerman, Oc
Urokinase Receptor Promotes Skin Tumor Formation by Preventing Epithelial Cell Activation of Notch1
2015-01-01 Mazzieri, R; Pietrogrande, G; Gerasi, L; Gandelli, A; Colombo, P; Moi, D; Brombin, C; Ambrosi, A; Danese, S; Mignatti, P; Blasi, F; D'Alessio, S
Verification of prostate cancer biomarker candidates by nanoparticle-capture MRM
2010-01-01 Fredolini, C; Luchini, A; Meani, F; Russo, P; Tamburro, D; Douglas, T; Longo, C; Gambara, G; Zhou, W; Ross, M; Novelli, F; Collura, D; Muto, G; Espina, V; Ornstein, D; Liotta, La; Petricoin, Ef
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Quantitative Assessment of the Complex Dynamics of G(1), S, and G(2)-M Checkpoint Activities | 1-gen-2009 | Ubezio, P; Lupi, M; Branduardi, D; Cappella, P; Cavallini, E; Colombo, V; Matera, G; Natoli, C; Tomasoni, D; D'Incalci, M | |
| Second primary tumors after breast cancer: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) study | 1-gen-2012 | Ricceri, F; Sacerdote, C; Critelli, R; Vineis, P; Riboli, E | |
| Selective expression and constitutive phosphorylation of SHC proteins [corrected] in the CD34+ fraction of chronic myelogenous leukemias | 1-gen-2000 | Bonati, A.; Carlo-Stella, C.; Lunghi, P.; Albertini, R.; Pinelli, S.; Migliaccio, E.; Sammarelli, G.; Savoldo, B.; Tabilio, A.; Dall'Aglio, P. P.; Pelicci, P. G. | |
| Specific histone patterns and acetylase/deacetylase activity at the breakpoint-cluster region of the human MLL gene | 1-gen-2004 | Khobta, A.; Carlo Stella, C.; Capranico, G. | |
| Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line | 1-gen-2005 | Zongaro, S; de Stanchina, E; Colombo, T; D'Incalci, M; Giulotto, E; Mondello, C | |
| Striking activity of E-3810 combined with paclitaxel and 5FU in the triple negative breast cancer model MDA-MB-231 | 1-gen-2011 | Damia, G; Bello, E; Colella, G; Berndt, A; D'Incalci, M; Cavalletti, E; Camboni, G | |
| Tenascin-W is a novel marker for activated tumor stroma in low-grade human breast cancer and influences cell behavior | 1-gen-2007 | Degen, M; Brellier, F; Kain, R; Ruiz, C; Terracciano, L; Orend, G; CHIQUET-EHRISMANN, R | |
| The anti-HLA-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing NOD/SCID mice | 1-gen-2006 | Carlo-Stella, C.; Di Nicola, M.; Turco, M. C.; Cleris, L.; Lavazza, C.; Longoni, P.; Milanesi, M.; Magni, M.; Ammirante, M.; Leone, A.; Nagy, Z.; Gioffrè, W. R.; Formelli, F.; Gianni, A. M. | |
| The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: Regulation of expression and potential mechanisms of antimalignant activity | 1-gen-2003 | Monti, P; Leone, Be; Marchesi, F; Balzano, G; Zerbi, A; Scaltrini, F; Pasquali, C; Calori, G; Pessi, F; Sperti, C; Di Carlo, V; Allavena, P; Piemonti, L | |
| TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: A prospective study | 1-gen-2006 | Gormally, E; Vineis, P; Matullo, G; Veglia, F; Caboux, E; Le Roux, E; Peluso, M; Garte, S; Guarrera, S; Munnia, A; Airoldi, L; Autrup, H; Malaveille, C; Dunning, A; Overvad, K; Tjonneland, A; Lund, E; Clavel-Chapelon, F; Boeing, H; Trichopoulou, A; Palli, D; Krogh, V; Tumino, R; Panico, S; Bueno-de-Mesquita, Hb; Peeters, Ph; Pera, G; Martinez, C; Dorronsoro, M; Barricarte, A; Navarro, C; Quiros, Jr; Hallmans, G; Day, Ne; Key, Tj; Saracci, R; Kaaks, R; Riboli, E; Hainaut, P | |
| Tumor hypoxia does not drive differentiation of tumor-associated macrophages but rather fine-tunes the M2-like macrophage population | 1-gen-2014 | Laoui, D.; Van Overmeire, E.; Conza, G. D.; Aldeni, C.; Keirsse, J.; Morias, Y.; Movahedi, K.; Houbracken, I.; Schouppe, E.; Elkrim, Y.; Karroum, O.; Jordan, B.; Carmeliet, P.; Gysemans, C.; Debaetselier, P.; Mazzone, M.; Van Ginderachter, J. A. | |
| Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model | 1-gen-2002 | Janssen, Ml; Oyen, W; Dijkgraaf, I; Massuger, Lf; Frielink, C; Edwards, Ds; Rajopadhye, M; Boonstra, H; Corstens, Fh; Boerman, Oc | |
| Urokinase Receptor Promotes Skin Tumor Formation by Preventing Epithelial Cell Activation of Notch1 | 1-gen-2015 | Mazzieri, R; Pietrogrande, G; Gerasi, L; Gandelli, A; Colombo, P; Moi, D; Brombin, C; Ambrosi, A; Danese, S; Mignatti, P; Blasi, F; D'Alessio, S | |
| Verification of prostate cancer biomarker candidates by nanoparticle-capture MRM | 1-gen-2010 | Fredolini, C; Luchini, A; Meani, F; Russo, P; Tamburro, D; Douglas, T; Longo, C; Gambara, G; Zhou, W; Ross, M; Novelli, F; Collura, D; Muto, G; Espina, V; Ornstein, D; Liotta, La; Petricoin, Ef |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile